ArticleFrontiers in medicine2026
Parapapillary retinal hemangioblastoma presenting as an epiretinal membrane in a patient with Von Hippel-Lindau disease: a case report.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Retinal hemangioblastoma (RH) is a benign, highly vascularized tumor arising from the neurosensory retina. It may occur sporadically or as a manifestation of Von Hippel-Lindau (VHL) disease. Here, we describe a case of parapapillary RH in a patient with VHL disease that presented clinically as an epiretinal membrane overlying the optic disc. Case description: A 6-year-old boy presented with an abnormality detected on left fundus examination. Fundus photography and optical coherence tomography revealed an epiretinal membrane on the temporal side of the optic disc causing retinal traction and deformation. Fundus fluorescein angiography demonstrated early hyperfluorescence within the lesion. Vitreoretinal surgery was performed with satisfactory visual recovery. Histopathological and immunohistochemical findings confirmed the diagnosis of RH. Genetic analysis identified a heterozygous splice-site mutation (c.464-2A>G) in the Conclusion: Parapapillary RH can masquerade as an epiretinal membrane over the optic disc, posing a diagnostic challenge. Histopathological confirmation and genetic evaluation are essential to establish the diagnosis and to identify underlying VHL disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.